Why did Lenskart jump to a record high today — then fade?

Lenskart opened Thursday with a bang. The eyewear retailer shot up as much as 6.8% to an all-time high of ₹626.95 on the NSE in early trade, before profit-takers pulled it back — it was changing hands around ₹608 (up roughly 3–4% on the day) by mid-morning, even as the Nifty 50 slipped about 0.4%, per Business Standard. Two things lit the fuse, and one thing capped it.
Why it moved
The trigger was Wednesday evening's June-quarter results. Lenskart's consolidated net profit jumped about 269% year-on-year to roughly ₹222 crore (from about ₹60 crore a year ago), while revenue rose ~43% to about ₹2,714 crore, as reported by Business Standard and Business Today. EBITDA came in near ₹589 crore, with margin around 21.7% — the profitability, not just the top-line, is what analysts latched onto. The mix mattered too: India revenue grew about 30.6% and the international business about 38%, and eye tests (the top of Lenskart's sales funnel) rose 39.8% to 7.1 million.
The second push was mechanical. Lenskart is being added to the MSCI India Domestic Index with effect from the close of Aug 31, 2026. Passive funds that track that index have to buy the stock when it goes in, regardless of price — and an index inclusion tends to pull that buying forward, which is part of why the open was so sharp.
The business
Lenskart isn't just a website. It's an omnichannel eyewear company — thousands of stores across India plus a growing overseas footprint (South-East Asia, the Middle East, and Japan through its Owndays buyout), its own in-house frame manufacturing, and house brands like Vincent Chase and John Jacobs. That vertical integration is the margin story: making its own frames and running its own stores lets it keep more of each rupee than a pure reseller would. It only listed in late 2025, so every quarter as a public company is still setting the bar for what "normal" looks like.
Is it expensive?
In a word — yes, richly. Even after the results, Lenskart trades near a P/E of ~215, with a market cap around ₹1.02 lakh crore and a price-to-book above 11 (Screener.in). Full-year FY26 net profit was about ₹494 crore, so the market is paying today for years of growth still to come. For context, two premium listed consumer names — Trent at roughly 90–100x earnings and Titan near 75–85x — are already expensive by normal standards, yet both sit at less than half Lenskart's multiple. That gap is exactly why a blockbuster quarter still got sold into: when a stock is priced for perfection, even a tripling of profit can already be "in the price".
Who it touches
- New-age consumer IPOs: Lenskart's print is a sentiment read-through for the recently-listed cohort — Groww (also in this MSCI round), FirstCry/Brainbees and Nykaa (FSN E-Commerce).
- Passive and index funds: MSCI trackers must add the stock by Aug 31 — a small but forced flow that isn't about the fundamentals.
- Optical rivals: Titan Eye+ and standalone optical chains are chasing the same growing "first pair of glasses" market Lenskart is scaling into.
What to watch
The one risk that flips the story is the valuation itself. At ~215x earnings, Lenskart has almost no cushion for a miss — a slowdown in international growth, a currency hit to margins, or one soft quarter could trigger a sharp de-rating. Today's fade from the record high is a live preview of how fast the crowd books profit when the price already assumes near-flawless execution.
As of ~12:20 PM IST, Aug 13, 2026. Sources: Business Standard, Business Today, Screener.in. For discussion and education only — not investment advice. Verify before acting.
This article is for educational and informational purposes only. It is not financial advice, investment recommendation, or a solicitation to buy or sell securities. Investing involves significant risks. I am not a SEBI-registered investment advisor. Readers should consult their own financial advisor and conduct their own research before making any investment decisions.
Comments
Join the conversation
Sign in to join the conversation.
Follow replies, add your view, and take part in the discussion.
Sign in to commentLoading comments...